Expression of Bcl-X(L) can confer a multidrug resistance phenotype

Blood

Volumn 86, Issue 5, 1995, Pages 1903-1910

  Minn, A J ^a   Rudin, C M ^a   Boise, L H ^a   Thompson, C B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CELL DEATH; GENE EXPRESSION; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL CYCLE; CELL SURVIVAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KINETICS; MULTIGENE FAMILY; TIME;

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; BCL-X PROTEIN; ONCOPROTEIN; PROTEIN BCL X; PROTO ONCOGENE PROTEINS; RECOMBINANT PROTEIN;

ANIMAL; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL SURVIVAL; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION; HUMAN; KINETICS; MICE; MULTIGENE FAMILY; PROTO-ONCOGENE PROTEINS; RECOMBINANT PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0028982183     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v86.5.1903.bloodjournal8651903     Document Type: Article

References (0)